MSCs that do not migrate well to tumor CM (MSC‐8, ‐21, and ‐22) exhibited a slight increase in levels of IGFBP2 in comparison with those with efficient migration potential (MSC‐1, ‐13, and ‐19). Here, IGFBP2 is linked to neoplasm.